Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.

Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA.

Clin Chem. 2013 Jul;59(7):1108-17. doi: 10.1373/clinchem.2012.201467.

2.

Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

Schwope DM, Karschner EL, Gorelick DA, Huestis MA.

Clin Chem. 2011 Oct;57(10):1406-14. doi: 10.1373/clinchem.2011.171777.

3.

In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.

Desrosiers NA, Lee D, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA.

Anal Bioanal Chem. 2014 Jan;406(3):785-92. doi: 10.1007/s00216-013-7524-7.

4.

Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.

Anizan S, Bergamaschi MM, Barnes AJ, Milman G, Desrosiers N, Lee D, Gorelick DA, Huestis MA.

Drug Test Anal. 2015 Feb;7(2):114-20. doi: 10.1002/dta.1688.

5.

Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.

Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA.

Clin Chem. 2014 Apr;60(4):631-43. doi: 10.1373/clinchem.2013.216507.

6.

Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.

Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA.

Clin Chem. 2011 Aug;57(8):1127-36. doi: 10.1373/clinchem.2011.164822.

7.

Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?

Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA.

Clin Chem. 2014 Feb;60(2):361-72. doi: 10.1373/clinchem.2013.214106.

8.

Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.

Schwope DM, Scheidweiler KB, Huestis MA.

Anal Bioanal Chem. 2011 Sep;401(4):1273-83. doi: 10.1007/s00216-011-5197-7.

9.

Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.

Lee D, Milman G, Schwope DM, Barnes AJ, Gorelick DA, Huestis MA.

Clin Chem. 2012 Jul;58(7):1101-9. doi: 10.1373/clinchem.2012.184929.

10.

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):68-76. doi: 10.1016/j.drugalcdep.2012.10.011.

11.

Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA.

Clin Chem. 2012 Apr;58(4):748-56. doi: 10.1373/clinchem.2011.177881.

12.

Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.

Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA.

Ther Drug Monit. 2014 Apr;36(2):218-24. doi: 10.1097/FTD.0b013e3182a5c446.

13.

Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.

Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA.

Clin Chem. 2013 Dec;59(12):1770-9. doi: 10.1373/clinchem.2013.207316.

14.

Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Milman G, Schwope DM, Gorelick DA, Huestis MA.

Clin Chim Acta. 2012 Apr 11;413(7-8):765-70. doi: 10.1016/j.cca.2012.01.011.

15.

Cannabinoids in exhaled breath following controlled administration of smoked cannabis.

Himes SK, Scheidweiler KB, Beck O, Gorelick DA, Desrosiers NA, Huestis MA.

Clin Chem. 2013 Dec;59(12):1780-9. doi: 10.1373/clinchem.2013.207407.

16.

Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

Milman G, Barnes AJ, Lowe RH, Huestis MA.

J Chromatogr A. 2010 Feb 26;1217(9):1513-21. doi: 10.1016/j.chroma.2009.12.053.

17.

Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

Huestis MA, Henningfield JE, Cone EJ.

J Anal Toxicol. 1992 Sep-Oct;16(5):276-82.

PMID:
1338215
18.

Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.

Anizan S, Milman G, Desrosiers N, Barnes AJ, Gorelick DA, Huestis MA.

Anal Bioanal Chem. 2013 Oct;405(26):8451-61. doi: 10.1007/s00216-013-7291-5.

19.

Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.

Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F.

J Anal Toxicol. 2005 Nov-Dec;29(8):782-9.

20.

Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.

Lee D, Vandrey R, Mendu DR, Murray JA, Barnes AJ, Huestis MA.

Drug Test Anal. 2015 Jun;7(6):494-501. doi: 10.1002/dta.1718.

Items per page

Supplemental Content

Support Center